Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Cook

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 14, 2023
Association of dynamic contrast-enhanced MRI and <sup>18</sup>F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancerSamuel J Withey, Kasia Owczarczyk, Mariusz T Grzeda, et al.
Clinical Nuclear Medicine|January 31, 2016
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic ReviewKa Kit Wong, Barbra S Miller, Benjamin L Viglianti, et al.
European Radiology|February 19, 2014
Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancerConnie Yip, Vicky Goh, Andrew Davies, et al.
Biomarkers in Cancer|June 19, 2019
Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and ImmunohistochemistryDavid K Woolf, Sonia P Li, Simone Detre, et al.
Nuclear Medicine Communications|May 31, 2019
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imagingAsim Afaq, Fergus Gleeson, Andrew Scarsbrook, et al.
Annals of Surgical Oncology|April 27, 2016
A Role for Tumor Volume Assessment in Resectable Esophageal CancerLucinda G C Tullie, Hyon-Mok Sohn, Janine Zylstra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2018
Discovery of pre-therapy 2-deoxy-2-<sup>18</sup>F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patientsMubarik A Arshad, Andrew Thornton, Haonan Lu, et al.
European Radiology|April 6, 2012
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trialsEric O Aboagye, Fiona J Gilbert, Ian N Fleming, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2020
Effect of <sup>18</sup>F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON TrialAndrew F Scarsbrook, David Bottomley, Eugene J Teoh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2016
Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using <sup>18</sup>F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility StudyMaarten R Grootendorst, Massimiliano Cariati, Sarah E Pinder, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 14, 2023
Association of dynamic contrast-enhanced MRI and <sup>18</sup>F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancerSamuel J Withey, Kasia Owczarczyk, Mariusz T Grzeda, et al.
Clinical Nuclear Medicine|January 31, 2016
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic ReviewKa Kit Wong, Barbra S Miller, Benjamin L Viglianti, et al.
European Radiology|February 19, 2014
Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancerConnie Yip, Vicky Goh, Andrew Davies, et al.
Biomarkers in Cancer|June 19, 2019
Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and ImmunohistochemistryDavid K Woolf, Sonia P Li, Simone Detre, et al.
Nuclear Medicine Communications|May 31, 2019
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imagingAsim Afaq, Fergus Gleeson, Andrew Scarsbrook, et al.
Annals of Surgical Oncology|April 27, 2016
A Role for Tumor Volume Assessment in Resectable Esophageal CancerLucinda G C Tullie, Hyon-Mok Sohn, Janine Zylstra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2018
Discovery of pre-therapy 2-deoxy-2-<sup>18</sup>F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patientsMubarik A Arshad, Andrew Thornton, Haonan Lu, et al.
European Radiology|April 6, 2012
Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trialsEric O Aboagye, Fiona J Gilbert, Ian N Fleming, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2020
Effect of <sup>18</sup>F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON TrialAndrew F Scarsbrook, David Bottomley, Eugene J Teoh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2016
Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using <sup>18</sup>F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility StudyMaarten R Grootendorst, Massimiliano Cariati, Sarah E Pinder, et al.
Pageof 5